Combined Synopsis Solicitation Commercial Services and Product Revised 2.6.2026.pdf

Attachment 1: Combined Synopsis-Solicitation for Commercial Services

Effective Date: 01/15/2026 Revision: 03

RFQ: 36C24226Q0287

Description This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format Revolutionary FAR Overhaul (RFO) in Federal Acquisition Regulation (FAR) subpart 12.202, “Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued.

This solicitation is issued as a Combined Synopsis/Solicitation RFQ 36C24226Q0287.

The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06.

This solicitation is a Full and Open competition. Contract Type: Indefinite Delivery/Indefinite Quantity (IDIQ), Firm-Fixed-Price (FFP) Contract.

The associated North American Industrial Classification System (NAICS) code for this procurement is 621511 Medical Laboratories, with a small business size standard of $41.5 Million.

The FSC/PSC is Q301 Medical-Reference Laboratory Testing.

The James J. Peters VAMC at 130 W. Kingsbridge, Bronx, NY 10468 is seeking to purchase a complete comprehensive full-service of Kidney Donor-Derived Cell-Free DNA Testing (CPT 81479).

All interested companies shall provide quotations for the following:

Supplies/Services

IDIQ Contract Minimum and Maximum: As this contract will be awarded as an IDIQ contract, the government will order a minimum quantity or value of $1,000 and a maximum quantity or value of $600,000. These limits apply to the total sum of all orders placed throughout the duration of the contract.

Line Item Description Quantity Unit of

Measure Unit Price

Total Price

0001 Comprehensive Specimen Collection and Testing Services:

Provide specimen collection kits, secure transport from NYVA to the testing site within 48 hours, Kidney Donor-Derived Cell-Free

1 EA $ $

https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-12#FAR_12_202

Revision: 03

RFQ: 36C24226Q0287

DNA Testing (CPT 81479), and deliver test results within 72 hours. Includes necessary supplies, equipment, and staff training on specimen collection and interpretation. Services shall be provided as indicated in the SOW. Estimated quantity is 30.

1001 Comprehensive Specimen Collection and Testing Services:

Provide specimen collection kits, secure transport from NYVA to the testing site within 48 hours, Kidney Donor-Derived Cell-Free DNA Testing (CPT 81479), and deliver test results within 72 hours. Includes necessary supplies, equipment, and staff training on specimen collection and interpretation. Services shall be provided as indicated in the SOW. Estimated quantity is 40.

1 EA $ $

2001 Comprehensive Specimen Collection and Testing Services:

Provide specimen collection kits, secure transport from NYVA to the testing site within 48 hours, Kidney Donor-Derived Cell-Free DNA Testing (CPT 81479), and deliver test results within 72 hours. Includes necessary supplies, equipment, and staff training on specimen collection and interpretation. Services shall be provided as indicated in the SOW. Estimated quantity is 45.

1 EA $ $

3001 Comprehensive Specimen Collection and Testing Services:

Provide specimen collection kits, secure transport from NYVA to the testing site within 48 hours, Kidney Donor-Derived Cell-Free DNA Testing (CPT 81479), and deliver test results within 72 hours. Includes necessary supplies, equipment, and staff

Revision: 03

RFQ: 36C24226Q0287

training on specimen collection and interpretation. Services shall be provided as indicated in the SOW. Estimated quantity is 45.

4001 Comprehensive Specimen Collection and Testing Services:

Provide specimen collection kits, secure transport from NYVA to the testing site within 48 hours, Kidney Donor-Derived Cell-Free DNA Testing (CPT 81479), and deliver test results within 72 hours. Includes necessary supplies, equipment, and staff training on specimen collection and interpretation. Services shall be provided as indicated in the SOW. Estimated quantity is 45.

Services shall be provided as indicated in the Statement of Work (SOW).

Statement of Work

Title: Donor-Derived Cell-Free DNA (dd-cfDNA) Testing Services

1. Introduction

The James J. Peters Bronx VA Medical Center (JJP VAMC) requires comprehensive donor-derived cell-free DNA (dd-cfDNA) testing kits and laboratory services to support the Renal Transplant Program. These services are intended to support post-transplant surveillance for kidney transplant recipients.

2. Background and Objective

Renal transplantation is a critical therapeutic option for patients with end-stage renal disease (ESRD). Ongoing post-transplant monitoring is essential to assess graft health, detect early signs of rejection, and guide timely clinical decision-making. Traditional monitoring methods, such as serum creatinine levels and invasive biopsies, may not detect subclinical graft injury promptly.

Donor-derived cell-free DNA (dd-cfDNA) testing is a non-invasive molecular diagnostic method that quantifies donor DNA fragments in a transplant recipient’s bloodstream.

Elevated levels may indicate allograft injury or immune-mediated rejection, allowing for earlier clinical intervention.

Revision: 03

RFQ: 36C24226Q0287

The objective of this contract is to support the JJP VAMC Renal Transplant surveillance program by providing dd-cfDNA testing services that:

• Deliver reliable and accurate test results within 72 hours of specimen receipt at the testing laboratory.

• Facilitate early detection of allograft injury or immune activation.

• Ensure secure handling, transmission, and confidentiality of patient information.

• Provide training and clinical interpretation support to VA staff upon request.

These services will enable VA clinicians to make timely, evidence-based decisions, reduce reliance on invasive diagnostic procedures, and improve transplant outcomes.

3. Scope of Work

The Contractor shall furnish all personnel, materials, equipment, supplies, transportation, supervision, and quality controls necessary to provide end-to-end dd-cfDNA testing services for kidney transplant recipients.

The scope includes:

• Provision of specimen collection kits.

• Mailing and Courier Services:

a. The Contractor shall ensure specimens are shipped via a reliable, trackable courier service that meets all applicable federal and VA requirements for biological specimen transport.

b. Courier must provide real-time tracking and delivery confirmation.

c. Specimens must arrive at the testing laboratory within 48 hours of collection.

d. Packaging must comply with Department of Transportation (DOT) UN3373 and International Air Transport Association (IATA) regulations for biological materials.

e. Contractor shall maintain chain-of-custody documentation for all shipments.

• The VA Staff will ensure that all donor-derived cell-free DNA (dd-cfDNA) testing kits are secured and, in a temperature-controlled package to ensure integrity of the specimen collection from JJP VAMC to the Contractor’s testing facility.

• Laboratory processing and analysis of specimens must be from a certified laboratory environment.

• Contractor shall secure transmission of test results via fax or a secure encrypted protected email.

• The Contractor shall provide training and clinical support services as outlined in this SOW.

Revision: 03

RFQ: 36C24226Q0287

All services and data handling shall comply with applicable federal laws and regulations, including the Health Insurance Portability and Accountability Act (HIPAA), VA Handbook 6500, and all VA information security requirements.

4. Performance Requirements

4.1 Testing Services

• The Contractor shall perform donor-derived cell-free DNA (dd-cfDNA) testing using CPT code 81479.

• All testing shall be conducted in a CLIA-certified and CAP-accredited laboratory.

• Test results shall be delivered within 72 hours of specimen receipt through a secure fax or an encrypted electronic transmission.

4.2 Specimen Collection and Transport

• The Contractor shall provide specimen collection kits to JJP VAMC Renal Transplant.

• The VA Staff will draw blood and package the blood from the transplant team.

• Specimens shall be transported securely and under temperature-controlled conditions to preserve specimen integrity, the testing kits will be packed with gel pack to avoid extreme temperature.

• All tests shall be tracked, with delivery to the testing laboratory occurring within 48 hours of specimen collection.

• The Transplant team will call the Contractor to inform that a pick-up for the specimen collected for that day needs to be picked up and processed.

4.3 Results Transmission and Data Security

• Test results shall be transmitted via secure fax or a secure encrypted electronic transmission to authorized VA clinical staff.

• All data transmissions and storage shall comply with HIPAA and PHI standards.

• The Contractor shall immediately notify the Contracting Officer’s Representative

(COR) and designated clinical staff if results cannot be delivered within the required timeframe, including the reason for delay and an estimated delivery time.

5. Tasks

Task 1: Donor-Derived Cell-Free DNA (dd-cfDNA) Testing

The Contractor shall:

• Receive and process specimens submitted by JJP VAMC Renal Transplant staff.

• Conduct dd-cfDNA testing accurately and in accordance with established laboratory protocols.

Revision: 03

RFQ: 36C24226Q0287

• Deliver test results within 72 hours of specimen receipt.

• Ensure confidentiality and integrity of patient data throughout the testing process.

Task 2: Specimen Collection Kit Management

The Contractor shall:

• Accept and fulfill orders for specimen collection kits submitted by JJP VAMC staff.

• Ensure timely delivery of kits to JJP VAMC.

• Provide instructions and documentation necessary for proper specimen collection and handling.

Task 3: Training and Clinical Support

Upon request, the Contractor shall provide:

• Initial onboarding training on specimen collection, submission procedures, and result interpretation.

• Ongoing clinical consultation to address questions regarding test results.

• Updated educational and training materials as testing methodologies or protocols change.

6. Deliverables

The Contractor shall provide the following deliverables:

• dd-cfDNA test result reports within 72 hours of specimen receipt.

• Monthly utilization and billing summaries submitted to the COR by the 5th calendar day of each month.

• Annual certification, accreditation, and compliance documentation.

• Training materials and attendance records when training is conducted.

• Immediate notification and documentation of any incidents, service disruptions, or deviations from requirements.

7. Quality Assurance and Performance Standards

The Contractor shall maintain quality assurance procedures sufficient to ensure accurate testing and timely delivery of results. Performance standards include:

• 100% test results delivered within the required 72-hour turnaround time.

• Documentation and reporting of any specimen rejection, retesting, or corrective actions.

• Cooperation with VA audits or reviews related to contract performance.

• Participate in External Proficiency Testing (EPT) programs.

Revision: 03

RFQ: 36C24226Q0287

8. Risk Mitigation

If the lab fails EPT, corrective actions are triggered before patient care is compromised.

The Contractor must provide the corrective action.

9. QCP (Quality Control Plan)

The contractor must provide a Quality Control Plan (QCP) detailing the procedures and measures to ensure the quality and compliance of all deliverables.

10. Estimated Quantities

The quantities specified are estimates only and do not represent a guarantee of services. The estimated annual testing volume is 30 to 45 dd-cfDNA tests per year.

11. Place of Performance

• Laboratory testing and specimen processing shall be performed at the Contractor’s facility.

• Specimen collection kits shall be delivered to:

James J. Peters VA Medical Center Renal Transplant, Room 4A-14 130 West Kingsbridge Road Bronx, NY 10468

12. Period of Performance

The IDIQ Ordering Period shall be five (5) years.

13. Qualifications, Certifications, and Licenses

The Contractor must maintain and provide documentation from the following prior to commence of work and upon request throughout the life cycle of the contract:

• Clinical Laboratory Improvement Amendments (CLIA) Certification.

• College of American Pathologists (CAP) Accreditation.

o CLIA certification and CAP accreditation must be maintained throughout the contract.

• Applicable federal and state laboratory licenses.

• Qualified laboratory personnel with appropriate training and proficiency testing.

• External Proficiency Testing (EPT) programs

14. Type of Contract

This is an IDIQ, FIRM FIXED PRICE contract.

Revision: 03

RFQ: 36C24226Q0287

15. Contracting Officer’s Representative (COR)

The COR will be designated by separate written appointment letter. The COR is responsible for monitoring technical performance and assisting with contract administration. The COR is not authorized to make changes affecting price, scope, or delivery terms.

16. Special Instructions

The Contractor shall comply with all applicable federal, state, and VA regulations governing patient safety, privacy, data security, and continuity of operations. The Contractor shall maintain contingency procedures to ensure continuity of testing services in the event of laboratory disruption.

17. Non-Compliance

The Contracting Officer or designee will notify the Contractor of any non-compliance and required corrective actions. Failure to promptly correct deficiencies may result in a stop-work order or default in accordance with contract terms.

18. Other Related Services (Not Included)

Any services not expressly stated in this Statement of Work are not authorized.

Additional services may be added only through written modification by the Contracting Officer. No other VA personnel are authorized to request additional work.

19. Definitions

1. dd-cfDNA (Donor-Derived Cell-Free DNA): Fragments of DNA originating from the transplanted organ, circulating in the recipient’s bloodstream. Elevated levels may indicate allograft injury or rejection.

2. COR (Contracting Officer’s Representative): The Government official designated to monitor technical performance and compliance with contract requirements.

3. PHI (Protected Health Information): Individually identifiable health information protected under HIPAA and VA privacy regulations.

4. QCP (Quality Control Plan): A documented plan outlining the Contractor’s internal processes to ensure accuracy, reliability, and compliance with contract requirements.

5. EPT (External Proficiency Testing): Independent testing programs that validate laboratory accuracy and compliance with industry standards.

Place of Delivery

Address: 130 W Kingsbridge Road, Bronx, NY

Revision: 03

RFQ: 36C24226Q0287

Postal Code: 10468 Country: UNITED STATES

The full text of FAR provisions or clauses may be accessed electronically at https://www.acquisition.gov/browse/index/far.

The following solicitation provisions and clause apply to this acquisition:

1. FAR 52.212-1, “Instructions to Offerors–Commercial Products and Commercial

Services”

ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (DEVIATION AUG 2025)

Provisions that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The version of FAR 52.212-1 in the addendum is tailored for Simplified Acquisition Procedures and supersedes the current version of FAR 52.212-1 contained in the FAR.

The following provision is incorporated into 52.212-1 as an addendum to this solicitation:

52.212-1 Instructions to Offerors—Commercial Products and Commercial Services (DEVIATION AUG 2025)

(a) Submission of offers. Submit signed and dated offers to the office specified in this solicitation at or before the exact time specified in this solicitation. As a minimum, offers shall include—

(1) The solicitation number 36C24226Q0287;

(2) The name, address, telephone number of the Offeror;

(3) The Offeror’s Unique Entity Identifier (UEI) and, if applicable, Electronic Funds Transfer (EFT) indicator;

(4) Information necessary to evaluate the factors contained in the provision at 52.212-2 or as described in the solicitation;

(5) Responses to provisions that require Offeror completion of information, representations, and certifications (other than those collected via the System for Award Management (SAM)); and

Revision: 03

RFQ: 36C24226Q0287

(6) A statement specifying the extent of agreement with all terms, conditions, and provisions included in the solicitation and any solicitation amendments.

(b) Period for acceptance of offers. The Offeror agrees to hold the prices in its offer firm for 60 calendar days from the date specified for receipt of offers, unless another time period is specified in an addendum to the solicitation.

(c) Late submissions, modifications, revisions, and withdrawals of offers.

(1) Offerors are responsible for submitting offers and any modifications or revisions to the Government office designated in the solicitation by the time specified in the solicitation.

(2) Any offer, modification, or revision received after the time specified for receipt of offers is “late” and will not be considered unless it is received before award is made and the Contracting Officer determines that accepting the late offer would not unduly delay the acquisition. However, a late modification of an otherwise successful offer that makes its terms more favorable to the Government will be considered at any time it is received and may be accepted.

(3) If an emergency or unanticipated event interrupts normal Government processes so that offers cannot be received at the Government office designated for receipt of offers by the exact time specified in the solicitation, and urgent Government requirements preclude amendment of the solicitation or other notice of an extension of the closing date, the time specified for receipt of offers will be deemed to be extended to the same time of day specified in the solicitation on the first work day on which normal Government processes resume.

(4) Offerors may withdraw their offers by written notice to the Government received at any time before award.

(d) Contract award (not applicable to Invitation for Bids). The Government intends to evaluate offers and award a contract without discussions with Offerors. Therefore, the Offeror’s initial offer should contain the Offeror’s best terms. However, the Government reserves the right to conduct discussions, if necessary. The Government may reject any or all offers if such action is in the public interest, accept other than the lowest offer, and waive informalities and minor irregularities in offers received.

(e) Debriefings. If a postaward debriefing is given to requesting Offerors, the Government will disclose the following information, if applicable:

Revision: 03

RFQ: 36C24226Q0287

(1) The agency’s evaluation of the significant weak or deficient factors in the debriefed Offeror’s offer.

(2) The overall evaluated cost or price and technical rating of the successful Offeror and the debriefed Offeror and past performance information on the debriefed Offeror.

(3) The overall ranking of all Offerors when any ranking was developed by the agency during source selection.

(4) A summary of the rationale for award.

(5) For acquisitions of commercial products, the make and model of the product to be delivered by the successful Offeror.

(6) Reasonable responses to relevant questions posed by the debriefed Offeror as to whether the agency followed source-selection procedures set forth in the solicitation, applicable regulations, and other applicable authorities.

(End of provision)

52.252-1 Solicitation Provisions Incorporated by Reference (FEB 1998) https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part- 52#FAR_52_252_1 (FAR) and http://www.va.gov/oal/library/vaar/index.asp (VAAR)

52.203-11 Certification and Disclosure Regarding Payments to Influence Certain Federal Transactions. (SEP 2024) 52.204-7 System for Award Management—Registration (NOV 2024) 52.209-7 Information Regarding Responsibility Matters (OCT 2018) (DEVIATION

NOV 2025)

52.219-1 Small Business Program Representations. (FEB 2024) (DEVIATION NOV 2025) 52.233-2 Service of Protest (SEP 2006) (DEVIATION NOV 2025)

(a) Protests, as defined in section 33.101 of the Federal Acquisition Regulation, that are filed directly with an agency, and copies of any protests that are filed with the Government Accountability Office (GAO), shall be served on the Contracting Officer (addressed as follows) by obtaining written and dated acknowledgment of receipt from Mariangie.Rivera@va.gov.

(b) The copy of any protest shall be received in the office designated above within one day of filing a protest with the GAO.

(End of provision) https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52#FAR_52_252_1 https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52#FAR_52_252_1 http://www.va.gov/oal/library/vaar/index.asp https://www.acquisition.gov/far/33.101#FAR_33_101 mailto:Mariangie.Rivera@va.gov

Revision: 03

RFQ: 36C24226Q0287

52.229-11 Tax on Certain Foreign Procurements – Notice and Representation (JUN

2020) (DEVIATION SEP 2025)

52.240-90 Security Prohibitions and Exclusions Representations and Certifications.

(DEVIATION NOV 2025)

852.215-72 Notice of Intent to Re-solicit (OCT 2019) 852.233-70 Protest Content/Alternative Dispute Resolution (SEP 2018) 852.233-71 Alternate Protest Procedure (SEP 2018) 852.252-70 Solicitation Provisions or Clauses Incorporated by Reference (JAN 2008)

All quoters MUST submit the following: Technical Capability, Past Performance, and Price.

All quotes shall be sent to the NCO 2 Contracting Officer Mariangie Rivera at Mariangie.Rivera@va.gov

2. FAR 52.212-2 Evaluation-Commercial Products and Commercial Services: In accordance with RFO FAR 12.201-1 and FAR 12.201-2 when appropriate, the contracting officer may (1) Insert the provision at 52.212-2, Evaluation-Commercial Products and Commercial Services, in solicitations for commercial products or commercial services.

(a) Evaluation factors. The Government will award a contract resulting from this solicitation to the responsible Offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The Government reserves the right to consider a quotation other than the lowest price that provides additional benefit(s). Quotations may exceed minimum requirements of the solicitation. The Government reserves the right to select a quotation that provides benefit to the Government that exceeds the minimum requirements of the solicitation but is not required to do so. Each response must meet the minimum requirements of the solicitation. The Government is accepting alternate quotations.

However, the Government may evaluate quotations using the comparative evaluation, where quotations will be compared to one another to determine which provides the best benefit to the Government.

The following factors will be used to evaluate offers:

Factor 1: Technical Capability

The Government will evaluate the extent to which the Offeror demonstrates in their capability statement the ability to successfully perform all requirements of the Statement of Work (SOW). Maximum 10 pages.

mailto:Mariangie.Rivera@va.gov https://www.acquisition.gov/far/part-52#FAR_52_212_2

Revision: 03

RFQ: 36C24226Q0287

The evaluation will assess the Offeror’s:

1. Technical Approach o Understanding of donor-derived cell-free DNA (dd-cfDNA) testing requirements for kidney transplant surveillance.

o Ability to meet required turnaround times (e.g., 72 hours from specimen receipt).

o Procedures for specimen handling, testing, result validation, and reporting.

2. Laboratory Qualifications and Compliance o Evidence of current CLIA certification and CAP accreditation.

o Compliance with applicable federal, VA, and information security requirements (e.g., HIPAA, VA Handbook 6500).

o Participation in External Proficiency Testing (EPT) programs.

Failure to submit evidence of current CLIA certification and CAP accreditation will result in rejection of quote.

3. Quality Control and Risk Management o Adequacy of the Quality Control Plan (QCP) to ensure accuracy, reliability, and continuity of services.

o Processes for addressing testing failures, delays, specimen rejections, or service disruptions.

4. Training and Clinical Support o Ability to provide training and clinical consultation support as required by the SOW.

o Availability and adequacy of educational materials and technical assistance.

Offerors will be evaluated to the degree to which they demonstrate a clear, feasible, and compliant technical solution with minimal risk to the Government.

Factor 2: Past Performance

The Government will evaluate the Offeror’s record of performing relevant and recent contracts for similar services.

Past performance will be evaluated based on:

• Relevance: Similarity in scope, complexity, and regulatory environment.

• Recency: Provide two to three performances within the past three (3) years.

• Quality of Performance: Timeliness, accuracy, customer satisfaction, compliance with contract requirements, and responsiveness to issues.

Sources of information may include, but are not limited to:

• CPARS and other Government databases, Revision: 03

RFQ: 36C24226Q0287

• References provided by the Offeror,

• Information obtained from Federal, state, or commercial customers.

Offerors without a record of relevant past performance will not be evaluated favorably or unfavorably.

Factor 3: Price

Price will be evaluated for reasonableness and completeness, not rated adjectivally.

The Government will assess whether:

• Prices are fair and reasonable

• Prices are consistent with the proposed technical approach.

• All required services are included and clearly priced.

Unbalanced pricing may render a proposal ineligible for award if it poses an unacceptable risk to the Government.

“Evaluations of Options"

For purposes of award of this Contract, the Government intends to evaluate the option to extend services under FAR 52.217-8 as follows: The evaluation will consider the possibility that the option can be exercised at any time and can be exercised in increments of one to six months, but not for more than a total of six months during the life of the contract. The evaluation will assume that the prices for any option exercised under FAR 52.217-8 will be those rates in effect under the contract each time an option is exercised under this clause. The evaluation will therefore assume that the addition of the price or prices of any possible extension or extensions under FAR 52.217-8 to the total price for the basic requirement and the total price for the priced options has the same effect on the total price of all proposals relative to each other, and will not affect the ranking of proposals based on price, unless, after reviewing the proposals, the Government determines that there is a basis for finding otherwise. This evaluation will not obligate the Government to exercise any option under FAR 52.217-8

(c) Notice of award. A written notice of award or acceptance of an offer furnished to the successful Offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.acquisition.gov%2Ffar%2Fpart-52&data=05%7C02%7C%7C6f48800884be427bb76408dc3e1d2789%7Ce95f1b23abaf45ee821db7ab251ab3bf%7C0%7C0%7C638453542134778598%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=AdaHSUvse3yIckDFYnd6vL%2BFpem1l7snmgnylt7orTk%3D&reserved=0 https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.acquisition.gov%2Ffar%2Fpart-52&data=05%7C02%7C%7C6f48800884be427bb76408dc3e1d2789%7Ce95f1b23abaf45ee821db7ab251ab3bf%7C0%7C0%7C638453542134788880%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=X5iAhxIdU0izIzSpKqfmChW6TUVm2fnXL8K0RXZBQCk%3D&reserved=0 https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.acquisition.gov%2Ffar%2Fpart-52&data=05%7C02%7C%7C6f48800884be427bb76408dc3e1d2789%7Ce95f1b23abaf45ee821db7ab251ab3bf%7C0%7C0%7C638453542134796534%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=Y9QHNv9a6%2Fhba%2Bzx0UzldhNn7BF1mA4LBDQkpkBXEks%3D&reserved=0 https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.acquisition.gov%2Ffar%2Fpart-52&data=05%7C02%7C%7C6f48800884be427bb76408dc3e1d2789%7Ce95f1b23abaf45ee821db7ab251ab3bf%7C0%7C0%7C638453542134802667%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=JhVGTNs%2FrUUtSKWrJ34GHDySdGuy3%2F9gSzw%2FI7hKB8U%3D&reserved=0

Revision: 03

RFQ: 36C24226Q0287

whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

3. NOTE: RFO FAR 52.212-3 is RESERVED. Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://sam.gov/.

4. FAR 52.212-4, “Contract Terms and Conditions–Commercial Products and Commercial Services” (NOV 2023) (DEVIATION OCT 2025)

52.252-2 Clauses Incorporated by Reference (FEB 1998) [Fill in as follows] https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52#FAR_52_252_2 (FAR) and http://www.va.gov/oal/library/vaar/index.asp (VAAR) 52.203-6 ALT I. Restrictions on Subcontractor Sales to the Government. (NOV 2021) 52.203-17 Contractor Employee Whistleblower Rights. (NOV 2023) 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements. (JAN 2017) 52.204-13 System for Award Management-Maintenance (OCT 2018) (DEVIATION NOV 2025) 52.209-6 Protecting the Government's Interest When Subcontracting With Contractors Debarred, Suspended, Proposed for Debarment, or Voluntarily Excluded. (JAN 2025)

(DEVIATION NOV 2025)

52.209-9 Updates of Publicly Available Information Regarding Responsibility Matters.

(OCT 2018) (DEVIATION NOV 2025)

52.209-10 Prohibition on Contracting With Inverted Domestic Corporations. (NOV 2015)

(DEVIATION NOV 2025)

52.216-18 Ordering (AUG 2020) 52.216-19 Order Limitations (OCT 1995) 52.216-22 Indefinite Quantity (OCT 1995) (DEVIATION NOV 2025) 52.217-8 Option to Extend Services (NOV 1999) 52.219-4 Notice of Price Evaluation Preference for HUBZone Small Business Concerns.

(OCT 2022) (DEVIATION NOV 2025)

52.219-28 Postaward Small Business Program Rerepresentation (JAN 2025)

(DEVIATION NOV 2025)

52.222-3 Convict Labor. (JUN 2003) (DEVIATION NOV 2025) 52.222-35 Equal Opportunity for Veterans. (JUN 2020) (DEVIATION NOV 2025) 52.222-36 Equal Opportunity for Workers with Disabilities. (JUN 2020) (DEVIATION

NOV 2025)

52.222-37 Employment Reports on Veterans. (JUN 2020) 52.222-40 Notification of Employee Rights Under the National Labor Relations Act.

(DEC 2010) (DEVIATION NOV 2025)

52.222-41 Service Contract Labor Standards. (AUG 2018) (DEVIATION NOV 2025) 52.222-42 Statement of Equivalent Rates for Federal Hires. (MAY 2014) https://sam.gov/ https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52#FAR_52_252_2 https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52#FAR_52_252_2 http://www.va.gov/oal/library/vaar/index.asp

Revision: 03

RFQ: 36C24226Q0287

52.222-43 Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (Multiple Year and Option Contracts). (AUG 2018) (DEVIATION NOV 2025) 52.222-49 Service Contract Labor Standards – Place of Performance Unknown (MAY

2014) (DEVIATION NOV 2025)

52.222-50 Combating Trafficking in Persons. (NOV 2021) (DEVIATION NOV 2025) 52.222-54 Employment Eligibility Verification. (JAN 2025) (DEVIATION NOV 2025) 52.222-55 Minimum Wages for Contractor Workers Under Executive Order 14026 (JAN

2022) (DEVIATION NOV 2025)

52.222-62 Paid Sick Leave Under Executive Order 13706. (JAN 2022) (DEVIATION

NOV 2025)

52.223-23 Sustainable Products. (MAY 2024) (DEVIATION NOV 2025) 52.225-8 Duty-Free Entry (OCT 2025) 52.226-8 Encouraging Contractor Policies to Ban Text Messaging While Driving. (MAY 2024) 52.229-3 Federal, State, and Local Taxes (FEB 2013) (DEVIATION SEP 2025) 52.232-19 Availability of Funds for the Next Fiscal Year (APR 1984) 52.232-33 Payment by Electronic Funds Transfer-System for Award Management.

(OCT 2018)

52.232-40 Providing Accelerated Payments to Small Business Subcontractors. (MAR 2023) 52.233-3 Protest after Award. (AUG 1996) (DEVIATION NOV 2025) 52.233-4 Applicable Law for Breach of Contract Claim. (OCT 2004) 52.244-6 Subcontracts for Commercial Products and Commercial Services. (JAN 2025)

(DEVIATION OCT 2025)

852.201-70 Contracting Officer’s Representative (DEC 2022) 852.203-70 Commercial Advertising (MAY 2018) 852.215-70 Service-Disabled Veteran-Owned and Veteran-Owned Small Business Evaluation Factors (OCT 2019) 852.215-71 Evaluation Factor Commitments (OCT 2019) 852.222-71 Compliance with Executive Order 13899 (DEVIATION) (APR 2025) 852.232-72 Electronic Submission of Payment Requests (NOV 2018) 852.242-71 Administrative Contracting Officer (OCT 2020)

To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows:

"The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition."

OR

"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"

Quoters shall list exception(s) and rationale for the exception(s), if any.

Revision: 03

RFQ: 36C24226Q0287

Request for Information by the interested vendor regarding clarifications and questions must be submitted no later than 02/12/2026 by 10:00 AM Eastern Standard Time (EST).

Submission of your response shall be received not later than 10:00AM EST on February 20, 2026, at Mariangie.Rivera@va.gov. A complete package must be submitted by the stated due date and time. A package submitted and received after 10:00 AM will be marked Late and risk no further consideration.

Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Point of Contact listed below.

Point of Contact Mariangie Rivera at Mariangie.Rivera@va.gov